GC

Gangadhar Chaubey

Active Director Director DIN 08044889
DIN 08044889 First appointment Feb 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Gangadhar Chaubey

Data last updated:

Gangadhar Chaubey is a Director at Zisel Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Zisel Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2020).

DIN 08044889
Primary Designation Director
Industry Trading
First Appointment 01 Feb 2019
Oldest Company Age 15 yrs
Largest company Zisel Pharmaceuticals Private Limited · ₹6 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20192011₹6 Lakh (FY 2020)Active

Board colleagues of Gangadhar Chaubey

NameDINCompanyDesignation
Sweta Pandey07973697Zisel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zisel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gangadhar Chaubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gangadhar Chaubey

Gangadhar Chaubey currently holds 1 directorship: Zisel Pharmaceuticals Private Limited (Director, since 01 Feb 2019, revenue ₹6 Lakh (FY 2020)).

Gangadhar Chaubey was first appointed on 01 Feb 2019 as Director at Zisel Pharmaceuticals Private Limited.

The current boards of Gangadhar Chaubey's companies include Sweta Pandey (Zisel Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available